| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SNGX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 10.0K | - | - | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2016 | Schaber Christopher J | Chairman, CEO And President | Buy | 15,804 | $3.16 | $49,939.06 | +170.1% | |
| Dec 16, 2016 | Brughera Marco Maria | Director | Buy | 2,000 | $3.16 | $6,319.80 | +266.7% | |
| Dec 16, 2016 | Rubin Robert J. | Director | Buy | 3,165 | $3.16 | $10,001.08 | +259.4% | |
| Dec 23, 2015 | Zeldis Jerome B45 | Director | Buy | 2,500 | $1.27 | $3,175.00 | +3.8% | |
| Dec 22, 2015 | Schaber Christopher J | Chairman, CEO And President | Buy | 10,000 | $1.29 | $12,878.00 | +13.2% |